Abstract
Angiotensin converting enzyme (ACE) is considered as main causative agent in growing hypertension and other cardiovascular disorders. Inhibition of ACE by producing and purifying bioactive peptides of fermented goat milk is aimed in this study. Protein extracted from goat milk was hydrolyzed with proteolytic enzymes of LH (Lactobacillus helveticus-cicc22171). ACE inhibitory peptides were purified from fermented samples of goat milk protein by optimizing incubation time to 8 h (S-8), 16 h (S-16), 24 h (S-24) and 36 h (S-36), via ultrafiltration. S-8 was used as control to compare the ACE inhibition trend. Molecular weight cut-off; 10000 Da (PM-10) and Ultracel 3K membrane was used to perform ultrafiltration. Sample with 24 h incubation time was considered as best hydrolyzed as compared to others, by applying Nin-Hydrin reaction and SDS-PAGE analysis. ACE inhibitory assay validated the authenticity of S-24 in inhibiting ACE, in vitro. Furthermore, Q executive hybrid quadrupole-orbitrap mass spectrometry was used to determine molecular structure and amino acid sequence of ACE inhibitory peptides. Three peptides, VLPVPQKAVPQ, VLPVPQKVVPQ and TQTPVVVPPFLQPEIMGVPKVKE containing functional amino acid structure, has been identified with highest ACE inhibitory activity on the basis of intensity, size and higher concentration of hydrophobic amino acids as shown in figure as graphical abstract. Fermented goat milk containing these novel bioactive peptides, can be used as nutraceuticals to inhibit ACE and control hypertension in future.
Graphical Abstract
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
The renin-angiotensin system (RAS) is a key player in maintaining the cardiovascular health with a continuous series of enzymatic reaction. Angiotensin 1 is produced in the blood as a result of cleavage in hepatic peptide angiotensinogen by renin. Angiotensin converting enzyme is main player to hydrolyze Ang 1 into Ang II and this Ang II increases vasoconstriction, inflammation, and oxidative stress in the vascular system via activation of AT1R (Bader and Ganten 2008). Angiotensin I-converting enzyme (ACE; kininase II; EC 3.4.15.1) is considered as main root cause of hypertension that is carboxy-dipeptidyl-metallopeptidase in nature and main linked enzyme of renin angiotensin system. It was first discovered in horse plasma, and spotted as an enzyme that was responsible to convert Ang I to Ang II (Skeggs et al. 1954; Helmer 1957). It was detected in human plasma a decade later (Yang and Erdös 1967). It is mainly involved in regulation of peripheral blood pressure along with catalyzes the production of Ang II from Ang I (a vasoconstrictor) and inactivation of the vasodilator bradykinin (Gobbetti et al. 2000; Kiom et al. 2004). Recently, ACE2 was discovered in RAS as a homologue of ACE that is responsible to breakdown Ang I into Ang 1–9 and Ang II into Ang 1–7, while Ang 1–7 is multifunctional bioactive peptide that works as ACE inhibitor. ACE2 is capable of hydrolyzing Ang 1–9 on one hand and generation of Ang 1–7 on the other hand (Mercure et al. 2008; Oudit and Penninger 2011; Alenina et al. 2008; Bader 2013).
Commonly, synthetic ACE inhibitors like captopril, enalapril, fosinopril, lisinopril, and ramipril are used to minimize the severity of hypertension but these synthetic inhibitors are encrypted with some side effects. So, It is need of hour to explore the natural resources of ACE inhibitors with some health promoting properties (Agostoni and Cicardi 2001; Chen et al. 2013). It has been known long ago about the importance of diet for human health. Recent studies confirmed the role of proteins especially milk proteins in reducing diseases (Groziak and Miller 2000; Das 2001). Milk bioactive peptides are considered as substitute of those synthetic inhibitors and it was reported that hydrolysis of milk protein can produce potent ACE inhibitory peptides (Yamada et al. 2013). Among other dairy species, goat milk is considered as a better choice in the production of ACE inhibitory peptides after fermentation (Parmar et al. 2018).
Recent debate among scientific community regarding exploitation of lactic acid bacteria has gained popularity due to proteolytic activity of LAB in producing bioactive peptides and functional food (Gobbetti et al. 2002). Proteolytic system, encrypted in Probiotic Lactobacillus, is responsible to break down protein into small peptides. In this way, Lactobacillus are involved in breaking down protein into small peptides during fermentation (Kilpi et al. 2007). When 28 strains of lactobacillus were evaluated to analyze best ACE inhibition in-vitro, only four strains including L. helveticus Showed remarkable ACE inhibitory activity (Chen et al. 2012).
Bioactive peptides from bovine milk are not a topic of interest for most of the scientific community due to known fermented profile of peptides and its effect. Now it is time to explore alternative sources like goat or sheep milk to extract bioactive peptides (Bernacka 2011). Due to difference in casein contents, goat milk is considered better than cow milk (Park et al. 2007).
As a second largest source of milk in the world after bovine milk, goat milk is rich in protein, fat, minerals, vitamins, and other nutrients as compared to bovine milk. Its protein profile is considered as close to the human milk due to abundance of smaller protein particles and short chained fatty acids (Belewu and Aiyegbusi 2002; López-Aliaga et al. 2010; Haenlein 2004). This study was designed to prevent the health loss due to cardiovascular diseases especially hypertension, with the introduction of functional food in daily life that can minimize the severity of hypertension. To meet the criteria of this study, fermented goat milk (hydrolyzed by LH in reducing hypertension with preconditions of optimizing incubation time) was used to produce and purify ACE inhibitory peptides on the basis of peptides structure, intensity of peptides in the fermented milk samples and concentration of aromatic and hydrophobic peptides.
Materials and Methods
Materials
Hippuryl-l-histidyl-l-leucine (Hip-His-Leu), purified rabbit lung ACE were purchased from Sigma Chemical Co. Ltd. Real Band 3-color highz Range Protein Marker (9–245 kDa) of reagent grade was purchased from BBI Life Sciences (Sangon Biotech Co. Ltd). Laboratory of Food Sciences (Beijing Forestry University) kindly donated stock culture of LH.
Ethics Statement
All policies mentioned in the code of ethical committee (Beijing Forestry University) for the use and care of animals, were adopted. Animal ethics committee of Beijing Forestry University approved the study design. Furthermore, Livestock department of Shaanxi province provided resources and manpower for milking.
Milk Collection and Preparation of Samples
Fresh Goat milk from apparently healthy and uninfected guanzhong goats was collected from guanzhong area of Shanxi Province in China. Guanzhong and Xinong Saanen breeds are leading dairy goats in China mainly due to population and milk yield. While, Guanzhong goat is a crossbreed of Xinong Saanen and local white goat of China. Its population is more than any other dairy goat breed reared in China. Concentration of milk protein in guanzhong goat is 3.52% while in Xinong Saanen dairy goat is 3.28%. Guanzhong goat was selected on the basis of its population and greater concentration of milk protein (Xu et al. 2003). Disinfectant solution (Safflon 20%) was used to wash the udder before milk collection. Milking was done in the daytime, 2 h after offering animals total mixed ration. Autoclaveable plastic containers (1000 mL) were used for the collection of samples and sterilized at 121 °C for 20 min (Omer and Eltinay 2008). Whole milk was converted into skim milk by centrifugation at 4000×g for 10 min at 15 °C and then stored at − 20 °C. Freeze-drying (Lyophilization) of skim goat milk was performed by Detianyou FD-1 Freeze Dryer (China Based Company). The freeze-dryer was programmed to operate at − 50 °C with a vacuum pressure of 20 pa (Pascal). After the end of freeze-drying cycle, dried milk was sealed under vacuum and stored at 5 °C until further analysis (Ivanova 2011).
Department of Food Sciences at Beijing Forestry University maintained stock culture of LH. Before experimental use, De Man, Rogosa and Sharpe (MRS) culture medium was prepared and stock culture was propagated for 16 to 18 h at 37 °C. Hemocytometer was used to calculate bacterial colonies and cells were harvested by centrifugation at 6000×g for 10 min at 4 °C and washed three times with distilled water.
Goat milk Protein was co-cultured with the LH (1 × 109 cfu/mL) at the ratio of 10:2 mL respectively. Moreover, Samples were incubated (37 °C) for the interval of 8, 16, 24 and 36 h.
Incubation temperature of LH was optimized at 37 °C because temperature was identified an important factor with higher influence on lactobacillus growth and activity of proteolytic enzyme (Shu et al. 2017). All experiments and co-culturing was done in sterile environment to avoid any contamination by surrounding environment.
Furthermore, samples were centrifuged at 15,000×g for 30 min and supernatant was filtered by using 0.45 µL (microliter) filter tip and stored at − 20 °C for further analysis.
Degree of Hydrolysis
Nin-Hydrin reaction was applied to estimate the degree of hydrolysis of protein into peptides. To prepare 20 mL solution, reagents were prepared according to standard protocol with 2 g (gram) of Na2HPO4·10H2O, 1.2 g NaH2PO4 × 2H2O, 0.1 g Nin-Hydrin and 0.06 g Fructose.
Each sample (S-8, S-16, S-24 and S-36) with the quantity of 0.05 mL was added into 15 mL of deionized water to dilute it further; 0.5 mL aliquot was taken and mixed with 1 mL reagent solution. Mixture was allowed to heat on 100 °C for 15 min. After heating, the color of samples turned into purple and its wavelength was examined at 570 nm by using Spectrophotometer (PGENERAL T-6 New century, China).
SDS-PAGE (Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis)
Gel electrophoresis was performed in a 10% separating gel along with 12% stacking gel. Separating and stacking gel was prepared according to standard protocol devised by Laemmli (1970). Electrophoretic separations was carried out by using a Bio-Rad Mini-Protein II Electrophoresis Cell System with a constant power supply of 18 mA/gel for 130 min after adding 15 µL samples into each well.
Polyacrylamide gel was stained with 0.25% (w/v) Coomassie R-250 Blue in 50% (v/v) methanol and 7.5% (v/v) acetic acid for 15–30 min (Laemmli 1970). Gel was destained in 20% (v/v) methanol and 7.5% acetic acid.
Ultrafiltration
Fermented goat milk peptides were divided into large and small (< 10,000 Da) molecular weight fractions through ultrafiltration. Extraction of bioactive peptides was performed according to the Jang and Lee method with some modifications (Jang and Lee 2005). Briefly, fermented milk samples were centrifuged at 10,000×g for 20 min at 4 °C. The supernatant was ultra-filtrated by PM-10 membrane, (molecular weight cut off 10,000; Millipore Corp., Billerica, MA) by optimizing temperature at 4 °C. Samples were centrifuged again, at 4000×g for 45 min at 4 °C and filtered using an Ultracel 3K membrane (MWCO, 3000; Millipore Corp., Billerica, MA).
Assay for ACE Inhibitory Activity
ACE inhibitory activity of the goat milk peptides was measured according to Cushman and Cheung (1971) with some modifications. Briefly, 50 µL of each sample (5 mM Hip-His-Leu in 0.1 M borate buffer containing 0.3 M NaCl, pH 8.3) was incubated with 50 µL of ACE at room temperature for 10 min. To this mixture, 200 µL of 5 mM Hip-His-Leu was added and incubated at 37 °C for half an hour. The reaction was then stopped by the addition of 1 N HCL weighing 200 µL. By the addition of 500 µL ethyl acetate, released hippuric acid was extracted and remaining ethyl acetate was removed by evaporation. Moreover, hippuric acid was redissolved in 1 mL distilled water and measured spectrophotometrically at 228 nm. Each sample was tested in triplicate. Without protein hydrolysate, the mixture was used as control.
Identification of Peptides
Q executive hybrid quadrupole-orbitrap mass spectrometry was used to identify peptides in the sample. This is a bench top LC-MS/MS system combines quadruple precursor ion selection with high-resolution, accurate-mass Orbitrap detection; mass range from 50 to 6000 m/z and scan range up to 12 Hz. Chromatographic separations were performed with Acclaim™ PepMap™ 100 C18 LC Columns (300 µm i.d. × 5 mm, packed with Acclaim PepMap RSLC C18, 5 µm, 100 Å, Nano Viper, Acclaim PepMap 75 µm × 150 mm, C18, 3 µm, 100A). Thermo Scientific™ Acclaim™ PepMap™ 100 C18 LC Column can produce high-resolution analysis of all type of peptides. Along with LC-MS/MS, these columns are often used for protein identification, decoding amino acid sequence in protein and systems biology. Equipped With the property of high loading capacity, these columns are right choice for the analysis of low abundant peptides in complex proteomics samples.
The mobile phase consisted of 0.1% formic acid in pure water (Solvent A) and 0.1% formic acid, 80% ACN (Solvent B), formed with gradient elution with following parameters: 0–5 min, 0–5% B; 5–25 min, 5–5% B; 25–30 min, 5–50% B; 25–30%, 50–90% B; 30–35 min, 90% B; 35–45 min, 5% B. The total run time was 40 min with a constant flow rate of 300 nL/min.
Some parameters in Orbitrap were as follows: spray voltage, 2.0 kV; capillary temperature, 250 °C; m/z (mass to charge ratio) range (ms), 350 to 1800. AGC (Automatic gain control) ion injection targets for first level FTMS (Fourier Transform Mass Spectrometry) scan were 70,000 (40 ms max injection time) with 3e6 AGS target and for second level mass spectrometry were 17,500 (60 ms max injection time) with 1e5 AGS target; 27NCE (normalized collisional energy) and 20 TopN.
Database Search
The original mass spectrum file was processed by MM File Conversion software, and then used MaxQuant to search the database.
Results and Discussion
Protein Hydrolysis and Peptides Purification
Main Aim of this study was to purify and identify Small peptides after hydrolysis of protein. To verify that proteins are hydrolyzing into peptides, Nin-Hydrin reaction was applied because it is widely used to analyze amino acids, peptides, and proteins in food and microbiological studies (Friedman et al. 1984; Pearce et al. 1988). Enzymes of LH were used to break down the protein into peptides. Degree of protein degradation into peptides by hydrolysis is called degree of hydrolysis (DH). It is one of most authentic mechanism to measure the hydrolysis process (Adler-Nissen 1979). It is also used as indicator of comparing different protein hydrolysates (Mahmoud 1994). Protein concentration decreased with its degradation into peptides as the incubation time rises and maximum hydrolysis was observed after 24 h. Degree of hydrolysis determined at various incubation times with LH is shown in Fig. 1.
Results of DH show the gradual decrease in protein contents from 8 to 24 h and it remains almost constant from 24 to 36 h, with negligible difference in protein degradation. It can be assumed on the basis of DH that 24 h were enough to hydrolyze milk protein with the help of LH enzymes.
SDS-PAGE was applied as next step to quantify the molecular mass of hydrolyzed protein. SDS-PAGE was mainly applied to determine the molecular mass of the hydrolyzing peptides, just like it was used in previous studies (Garcia-Mora et al. 2015). A representative SDS-PAGE of the samples with different incubation time is shown in Fig. 2. This result endorses the outcome of Fig. 1.
Major changes while performing SDS-PAGE included decrease in several bands indicated greater enzymatic breakdown by 24-h incubation. Samples with 24 h and 36 h incubation time, represented almost same picture of hydrolysis that indicated importance of 24-h incubation sample.
Moreover, filtration of samples with PM-10 membrane (molecular weight cut-off; 10 kDa) was done to further purify ACE inhibitory peptides. Samples were lyophilized after purification and concentrated in distilled water. Different steps in separation and purification techniques were recommended in previous study, were followed (Jinyu 2006). For ultra-filtration, Ultracel 3K-membrane was used (under 3000 Da) and small peptides were purified. Membrane technology is used to purify peptides on larger scale.
ACE Inhibition Pattern
All four samples were tested to evaluate their potency to inhibit ACE production by applying ACE assay, in vitro. Although, It was confirmed that S-24 was best hydrolyzed by previous tests and expected to show better inhibitory activity due to greater concentration peptides, but all samples were tested against ACE to further authenticate results. A clear increasing trend of ACE inhibitory activity has been observed with increasing incubation time of fermented samples, and after 24 h, increasing trend was as slow as negligible. It was reported previously that proteolytic activity of lactobacillus (Lactobacillus Plantarum) is at its peak at 24 h of fermentation (Gonzalez-Gonzalez et al. 2011). It was clear after running assay that S-24 was the sample to further evaluate for its peptides profile. Figure 3, indicated the increasing trend of ACE inhibition percentage with increasing time.
After 8 h of incubation 51.11% ACE inhibitory percentage was observed that increased gradually with time and after 16-h, it rose to 62.23%. Further increase in time to incubate samples, showed increase in inhibition of ACE by 72.32% after 24 h and 73.98% after 36 h.
Identification of Peptides
A total of 1257 small and large peptides were identified in this experiment. Among those, five peptides were identified with greater concentration and smaller peptides structure while the rest of peptides were detected in very lower concentration. Milk sample (D-24) used for the detection of peptide profile was collected from four different sources of same breed and then mixed after fermentation and hydrolysis step because replicates of each sample was showing almost same hydrolysis percentage and peptides concentration.
Five most abundant Peptides with low molecular weight were identified as shown in Table 1.
They were categorized on the basis of intensity and abundance of peptide in the sample, presence of hydrophobic and aromatic amino acids. Peptide sequence, with molecular weight of 2532.4026 Da and PID-1073 (peptide identification number), was categorized as the most abundant peptide on the basis of mass to charge ratio (m/z) which was recorded 1267.72 in Fig. 4a. It was identified with retention time of 41.785, 41.824, 44.933 and 44.944 min. Low molecular weight peptide (917.506 Da) with the retention time of 25.411, 27.137 and 27.93 min was identified thrice in S-24. Mass spectrum of PID-1045 was 459.76 m/z as shown in Fig. 4b. Third and fifth peptides with PVP, VVP sequence contested for potential ACE inhibitory peptides. PID-1136 with two times spectroscopic identification and retention time of 21.494 and 21.519 min while PID-1138 with one time identification with retention time of 25.318 min, was explained in Fig. 4c, e. Molecular weight of PID-1136 and 1138 was 1174.707 and 1202.738 Da respectively; PID-1136 with leading razor protein number Q712N8 was identified after 35 scans containing 6 isotopic peaks while PID 1138 with leading razor protein number Q95L76, was identified after 52 scans containing 5 isotopic peaks. Furthermore, PID 826 was identified once with retention time of 21.648 min. Its molecular weight was 1300.625 Da explained spectroscopically in Fig. 4d. PID 826 with leading razor protein number Q95L76 was identified once after 26 scans containing 6 isotopic peaks.
It was reported earlier that many ACE inhibitory peptides consist of 2–12 amino acids (Byun and Kim 2002), and peptides less than 3 kDa could be responsible for most of the ACE inhibitory activity (Moreno-Montoro et al. 2017; Espejo-Carpio et al. 2013). In this study, results indicated that out of five most abundant peptides, four (TLTDVEKL, VLPVPQKAVPQ, REQEELNVVGE, VLPVPQKVVPQ) consisted of less than 12 peptides and all five peptides are smaller than 3 kDa. Short chain peptides are less prone to proteolytic enzymes of small intestine after oral administration and easily absorbable to the absorptive cells because intestinal cells are restricted to absorb ultra-small peptides. Peptides with higher concentration of hydrophobic peptides and Proline residues are expected to pass the digestive enzymes intact (Meisel 2004; Ibrahim et al. 2017) due to their resistance against digestive enzymes (Vermeirssen et al. 2004; Norris et al. 2014) while higher concentration of Proline in PID 1073 (TQTPVVVPPFLQPEIMGVPKVKE), PID 1136 (VLPVPQKAVPQ), and PID 1138 (VLPVPQKVVPQ) showed that those peptides can have the ability to bypass digestive enzymes if tested in-vivo. On the other hand, peptides detected in S-24 showed ACE inhibitory activity, in vitro and it might assume that these peptides will remain intact in the gut and intestine of human, rather than degrading by proteolytic enzymes and might be absorbed easily through intestinal cells because of their smaller structure with low molecular weight.
Some ACE inhibitory peptides contain tyrosine, phenylalanine and tryptophan on C-terminal (Shahidi and Mine 2005) and presence of phenylalanine on C-terminal of PID 1136 and 1138 indicates its ACE inhibitory role. C-terminal hydrophobic amino acid residues specially methionine and valine, was observed on the in PID 1073, 1136, 1138 respectively, while it was stated in a study that C-terminal hydrophobic amino acid residues are responsible for ACE inhibition that comes from goat milk (Ibrahim et al. 2017). It is stated in some studies that ACE-inhibitory peptides encoded in natural foods and products contain basic amino acid residues (Suetsuna and Nakano 2000; Pripp et al. 2004) that further supports our finding by exhibiting the presence of Lysine in all peptides with higher presence of Proline in PID 1073 followed by PID 1136 and 1138. Greater quantity of amino acid with aromatic side chains in a sample may increase the ACE-inhibitory activity (Cian et al. 2013; Chalé et al. 2014; Udenigwe and Aluko 2011), while our findings are in agreement by the identification of amino acid with higher concentration of aromatic amino acid residues on C-terminal of PID 1136 and 1138. Methiotine, Triptophane, and Valine in P-1073, 1045, 1136 and 1138 on C-terminal indicated the greater hydrophobicity of this peptide and greater hydrophobicity of C-cleavage shows the greater ACE inhibitory activity (He et al. 2012). N-terminal with Aliphatic amino acid might increase ACE inhibitory activity (Cheung et al. 1980), While in this study, aliphatic amino acid Leucine and Valine was identified in PID-1073, 1136 and 1138 respectively. Leucine and Valine, with small N-terminal amino acids and strong hydrophobicity are more appropriate for ACE inhibitory activity (Wu et al. 2006) and same amino acids were found on N-terminal of P-1073, 1136 and 1138.
Conclusion
Incubation of goat milk protein with LH for 8 h was considered as control, related to other samples. With increase in fermentation time, increase in protein hydrolysis into peptides was observed. In this way, LH showed its prominent role to hydrolyze protein into bioactive peptides. Further, spectroscopic analysis of those peptides showed that molecular mass of peptides (peptide length) was not the only important factor to evaluate its functional activities; other factors including presence and intensity of aromatic and hydrophobic amino acid and amino acid sequence played an important role. In this study, fermented goat milk peptides, by optimizing incubation time to 24 h, were proved to exhibit remarkable ACE- inhibitory activity. Three ACE-inhibitory peptides, PID-1073 (TQTPVVVPPFLQPEIMGVPKVKE), PID-1136 (VLPVPQKAVPQ) and 1138 (VLPVPQKVVPQ), with functional group attached were identified by Q executive hybrid quadrupole-orbitrap mass spectrometery after 24 h of fermentation. Furthermore, structural analysis, intensity and presence of hydrophobic/aromatic amino acid concentration provided clear picture of their mode of action. In the light of previous research and our results, it can be documented that peptides with smaller molecular size with greater concentration are not only responsible in ACE inhibition in-vitro but amino acid sequence also play significant role also. So, It is concluded that Goat milk peptides fermented with LH after optimizing incubation time to 24 h can be used as functional food or nutraceuticals in treating hypertension and consumption of this fermented goat milk may lead to prevent the cardiovascular disorders. This bioactive food without side effects, can replace synthetic drugs.
References
Adler-Nissen J (1979) Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 27:1256–1262
Agostoni A, Cicardi M (2001) Drug-induced angioedema without urticaria. Drug Saf 24:599–606
Alenina N, Xu P, Rentzsch B, Patkin EL, Bader M (2008) Genetically altered animal models for Mas and angiotensin-(1–7). Exp Physiol 93:528–537
Bader M (2013) ACE2, angiotensin-(1–7), and Mas: the other side of the coin. Pflügers Archiv-Eur J Physiol 465:79–85
Bader M, Ganten D (2008) Update on tissue renin–angiotensin systems. J Mol Med 86:615
Belewu M, Aiyegbusi O (2002) Comparison of the mineral content and apparent biological value of milk from human, cow and goat. J Food Technol Afr 7:9–11
Bernacka H (2011) Health-promoting properties of goat milk. Medycyna Weterynaryjna 67:507–511
Byun H-G, Kim S-K (2002) Structure and activity of angiotensin I converting enzyme inhibitory peptides derived from Alaskan pollack skin. BMB Rep 35:239–243
Chalé FGH, Ruiz JCR, Fernández JJA, Ancona DAB, Campos MRS (2014) ACE inhibitory, hypotensive and antioxidant peptide fractions from Mucuna pruriens proteins. Process Biochem 49:1691–1698
Chen H, Ji Z, Shu GW, Xing HN (2012) Effect of probiotic Lactobacillus strains on angiotensin I converting enzyme inhibitory activity from fermented goat milk. In Advanced materials research, vol. 531. Trans Tech Publications, pp. 442–445
Chen J, Wang Y, Ye R, Wu Y, Xia W (2013) Comparison of analytical methods to assay inhibitors of angiotensin I-converting enzyme. Food Chem 141:3329–3334
Cheung H-S, Wang F-l, Ondetti MA, Sabo EF, Cushman DW (1980) Binding of peptide substrates and inhibitors of angiotensin-converting enzyme. Importance of the COOH-terminal dipeptide sequence. J Biol Chem 255:401–407
Cian RE, Alaiz M, Vioque J, Drago SR (2013) Enzyme proteolysis enhanced extraction of ACE inhibitory and antioxidant compounds (peptides and polyphenols) from Porphyra columbina residual cake. J Appl Phycol 25:1197–1206
Cushman D, Cheung H (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20:1637–1648
Das UN (2001) Nutritional factors in the pathobiology of human essential hypertension. Nutrition 17:337–346
Espejo-Carpio FJ, De Gobba C, Guadix A, Guadix EM, Otte J (2013) Angiotensin I-converting enzyme inhibitory activity of enzymatic hydrolysates of goat milk protein fractions. Int Dairy J 32:175–183
Friedman M, Pang J, Smith G (1984) Ninhydrin-reactive lysine in food proteins. J Food Sci 49:10–13
Garcia-Mora P, Peñas E, Frías J, Gomez R, Martinez-Villaluenga C (2015) High-pressure improves enzymatic proteolysis and the release of peptides with angiotensin I converting enzyme inhibitory and antioxidant activities from lentil proteins. Food Chem 171:224–232
Gobbetti M, Ferranti P, Smacchi E, Goffredi F, Addeo F (2000) Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckiisubsp. bulgaricus SS1 and Lactococcus lactissubsp cremoris FT4. Appl Environ Microbiol 66:3898–3904
Gobbetti M, Stepaniak L, De Angelis M, Corsetti A, Di Cagno R (2002) Latent bioactive peptides in milk proteins: proteolytic activation and significance in dairy processing. Crit Rev Food Sci Nutr 42:223–239
Gonzalez-Gonzalez C, Tuohy K, Jauregi P (2011) Production of angiotensin-I-converting enzyme (ACE) inhibitory activity in milk fermented with probiotic strains: effects of calcium, pH and peptides on the ACE-inhibitory activity. Int Dairy J 21:615–622
Groziak SM, Miller G (2000) Natural bioactive substances in milk and colostrum: effects on the arterial blood pressure system. Br J Nutr 84:119–125
Haenlein G (2004) Goat milk in human nutrition. Small Ruminant Res 51:155–163
He R, Ma H, Zhao W, Qu W, Zhao J, Luo L, Zhu W (2012) Modeling the QSAR of ACE-inhibitory peptides with ANN and its applied illustration. Int J Pept. https://doi.org/10.1155/2012/620609
Helmer O (1957) Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta. Am J Physiol-Leg Content 188:571–577
Ibrahim HR, Ahmed AS, Miyata T (2017) Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk. J Adv Res 8:63–71
Ivanova S (2011) Dynamical changes in the trace element composition of fresh and lyophilized ewe’s milk. Bul J Agr Sci 17:25–30
Jang A, Lee M (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci 69:653–661
Jinyu HJZYS (2006) Progress of antihypertensive peptide research. Food Ferment Ind 6:024
Kilpi E-R, Kahala M, Steele J, Pihlanto A, Joutsjoki V (2007) Angiotensin I-converting enzyme inhibitory activity in milk fermented by wild-type and peptidase-deletion derivatives of Lactobacillus helveticus CNRZ32. Int Dairy J 17:976–984
Kiom J, Lee D, Chung K, Jeong S, Lee J (2004) Characterization of antihypertensive angiotensin I-converting enzyme inhibitor from Saccharomyces cerevisiae. J Microbiol Biotechnol 14:1318–1323
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680
López-Aliaga I, Díaz-Castro J, Alférez MJM, Barrionuevo M, Campos MS (2010) A review of the nutritional and health aspects of goat milk in cases of intestinal resection. Dairy Sci Technol 90:611–622
Mahmoud MI (1994) Physicochemical and functional properties of protein hydrolysates in nutritional products. Food Technol 48:89–113
Meisel H (2004) Multifunctional peptides encrypted in milk proteins. Biofactors 21:55–61
Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL (2008) Angiotensin (1–7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ Res 103:1319–1326
Moreno-Montoro M, Olalla-Herrera M, Rufián-Henares J, Martínez RG, Miralles B, Bergillos T, Navarro-Alarcón M, Jauregi P (2017) Antioxidant, ACE-inhibitory and antimicrobial activity of fermented goat milk: activity and physicochemical property relationship of the peptide components. Food Funct 8:2783–2791
Norris R, Poyarkov A, O’Keeffe MB, FitzGerald RJ (2014) Characterisation of the hydrolytic specificity of Aspergillus niger derived prolyl endoproteinase on bovine β-casein and determination of ACE inhibitory activity. Food Chem 156:29–36
Omer R, Eltinay A (2008) Microbial quality of camel’s raw milk in central & southern regions of United Arab Emirates. J Food Agric 20:76–83
Oudit GY, Penninger JM (2011) Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy. Curr Heart Fail Rep 8:176–183
Park Y, Juárez M, Ramos M, Haenlein G (2007) Physico-chemical characteristics of goat and sheep milk. Small Ruminant Res 68:88–113
Parmar H, Hati S, Sakure A (2018) In vitro and in silico analysis of novel ACE-inhibitory bioactive peptides derived from fermented goat milk. Int J Pept Res Ther 24:441–453
Pearce KEN, Karahalios DA, Friedman ME (1988) Ninhydrin assay for proteolysis in ripening cheese. J Food Sci 53:432–435
Pripp AH, Isaksson T, Stepaniak L, Sørhaug T (2004) Quantitative structure-activity relationship modelling of ACE-inhibitory peptides derived from milk proteins. Eur Food Res Technol 219:579–583
Shahidi F, Mine Y (2005) Nutraceutical proteins and peptides in health and disease. CRC Press, Boca Raton
Shu G, Shi X, Chen H, Ji Z, Meng J (2017) Optimization of goat milk with ace inhibitory peptides fermented by Lactobacillus bulgaricus lb6 using response surface methodology. Molecules 22:2001
Skeggs LT, Marsh WH, Kahn JR, Shumway NP (1954) The existence of two forms of hypertensin. J Exp Med 99:275–282
Suetsuna K, Nakano T (2000) Identification of an antihypertensive peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem 11:450–454
Udenigwe CC, Aluko RE (2011) Chemometric analysis of the amino acid requirements of antioxidant food protein hydrolysates. Int J Mol Sci 12:3148–3161
Vermeirssen V, Van Camp J, Verstraete W (2004) Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br J Nutr 92:357–366
Wu J, Aluko RE, Nakai S (2006) Structural requirements of angiotensin I-converting enzyme inhibitory peptides: quantitative structure–activity relationship study of di-and tripeptides. J Agric Food Chem 54:732–738
Xu G, Pu J, Chen T (2003) On development status and countermeasures of goat industry in western China. China Herbivores Suppl 1:31–32
Yamada A, Sakurai T, Ochi D, Mitsuyama E, Yamauchi K, Abe F (2013) Novel angiotensin I-converting enzyme inhibitory peptide derived from bovine casein. Food Chem 141:3781–3789
Yang H, Erdös E (1967) Second kininase in human blood plasma. Nature 215:1402
Acknowledgements
I am really thankful to the Zhao Hongfei, Lecturer (Beijing Forestry University), for providing me all opportunities to run experiments and Dr. Shumaila Firdos (Animal Disease Investigation Officer, Punjab, Pakistan) in writing the article. This research was done with the funding of Beijing Key Laboratory of Food Processing and Safety, School of Biological Sciences and Technology, Beijing Forestry University (China).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Aslam, M.Z., Shoukat, S., Hongfei, Z. et al. Peptidomic Analysis of ACE Inhibitory Peptides Extracted from Fermented Goat Milk. Int J Pept Res Ther 25, 1259–1270 (2019). https://doi.org/10.1007/s10989-018-9771-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10989-018-9771-0